Literature DB >> 8293848

Monocyte-mediated enhancement of endometrial cell proliferation in women with endometriosis.

D P Braun1, A Muriana, H Gebel, C Rotman, N Rana, W P Dmowski.   

Abstract

OBJECTIVE: To investigate the capacity of monocytes from women with endometriosis to influence endometrial cell proliferation.
DESIGN: Uterine endometrial cells were cultured in the presence and absence of autologous blood monocytes for 72 hours before assessment of endometrial cell proliferation by thymidine incorporation.
SETTING: Patients were tested at initial presentation for evaluation of infertility and/or endometriosis. PATIENTS, PARTICIPANTS: Fertile controls, n = 17; infertile controls, n = 9; untreated endometriosis, n = 29.
INTERVENTIONS: None.
RESULTS: Endometrial cell proliferation was enhanced significantly by blood monocytes in patients with endometriosis but was suppressed significantly by blood monocytes in fertile controls. Endometrial cell proliferation was not affected significantly by blood monocytes in infertile controls analyzed as a group, but a subset of infertile patients also showed enhancement of endometrial cell proliferation by blood monocytes.
CONCLUSIONS: Blood monocytes from patients with endometriosis and a subset of patients with unexplained infertility enhance autologous endometrial cell proliferation, whereas blood monocytes from fertile patients suppress endometrial cell proliferation. The capacity of monocytes to enhance endometrial cell proliferation appears to require both monocyte-derived factors that stimulate endometrial cell proliferation and endometrial cells capable of responding to those stimulatory factors. If either of these factors is absent, monocytes either suppress or have no effect on endometrial cell proliferation.

Entities:  

Mesh:

Year:  1994        PMID: 8293848     DOI: 10.1016/s0015-0282(16)56456-5

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  9 in total

Review 1.  The endometrial immune environment of women with endometriosis.

Authors:  Júlia Vallvé-Juanico; Sahar Houshdaran; Linda C Giudice
Journal:  Hum Reprod Update       Date:  2019-09-11       Impact factor: 15.610

2.  Increased expression of monocyte chemotactic protein-1 in the endometrium of women with endometriosis.

Authors:  C Jolicoeur; M Boutouil; R Drouin; I Paradis; A Lemay; A Akoum
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

3.  Peritoneal fluid levels of immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP) in healthy and endometriosic women.

Authors:  P Florio; M Busacca; M Vignali; P Viganò; R J Woods; P J Lowry; A R Genazzani; S Luisi; M Santuz; F Petraglia
Journal:  J Endocrinol Invest       Date:  1998-01       Impact factor: 4.256

4.  The importance of endometrial nerve fibers and macrophage cell count in the diagnosis of endometriosis.

Authors:  Cihan Cetin; Hasan Serdaroglu; Sitki Tuzlali
Journal:  Iran J Reprod Med       Date:  2013-05

Review 5.  Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target.

Authors:  Chiara Agostinis; Andrea Balduit; Alessandro Mangogna; Gabriella Zito; Federico Romano; Giuseppe Ricci; Uday Kishore; Roberta Bulla
Journal:  Front Immunol       Date:  2021-01-11       Impact factor: 7.561

6.  The Inflammatory Feed-Forward Loop Triggered by the Complement Component C3 as a Potential Target in Endometriosis.

Authors:  Chiara Agostinis; Sonia Zorzet; Andrea Balduit; Gabriella Zito; Alessandro Mangogna; Paolo Macor; Federico Romano; Miriam Toffoli; Beatrice Belmonte; Gaia Morello; Anna Martorana; Violetta Borelli; Giuseppe Ricci; Uday Kishore; Roberta Bulla
Journal:  Front Immunol       Date:  2021-08-13       Impact factor: 7.561

7.  Deep immunophenotyping reveals endometriosis is marked by dysregulation of the mononuclear phagocytic system in endometrium and peripheral blood.

Authors:  Ashley F George; Sushmita Sen; Alexis J Combes; Linda C Giudice; Júlia Vallvé-Juanico; Reuben Thomas; Min-Gyoung Shin; Divyashree Kushnoor; Joshua J Vásquez; Kim Chi Vo; Juan C Irwin; Nadia R Roan
Journal:  BMC Med       Date:  2022-04-15       Impact factor: 11.150

8.  Tofacitinib alters STAT3 signaling and leads to endometriosis lesion regression.

Authors:  Alexander M Kotlyar; Ramanaiah Mamillapalli; Valerie A Flores; Hugh S Taylor
Journal:  Mol Hum Reprod       Date:  2021-03-24       Impact factor: 4.025

9.  Blood soluble interleukin 1 receptor accessory protein levels are consistently low throughout the menstrual cycle of women with endometriosis.

Authors:  Nadège Michaud; Mahera Al-Akoum; Ali Akoum
Journal:  Reprod Biol Endocrinol       Date:  2014-06-16       Impact factor: 5.211

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.